Trending
Stocks.org
You are at:»»Oversold Stocks: Equal Energy (NYSE:EQU), Mitek Systems (NASDAQ:MITK), Leidos Holdings (NYSE:LDOS), Exelixis, Inc. (NASDAQ:EXEL)
leidos

Oversold Stocks: Equal Energy (NYSE:EQU), Mitek Systems (NASDAQ:MITK), Leidos Holdings (NYSE:LDOS), Exelixis, Inc. (NASDAQ:EXEL)

342
By on BioPharma, Consumer Staples, Economy, Energy & Solar, S&P 500, Street Watch, Technology & Software

Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Western District of Oklahoma on behalf of investors who held Equal Energy Ltd. (NYSE:EQU) common stock on December 9, 2013. On last trading day Equal Energy Ltd. (USA) (NYSE:EQU) ended up -0.67%lower to close at $4.47 while trading in the range of $4.43 – $4.52. Its return on assets (ROA) is 27.70% while return on investment (ROI) is 18.40%.Equal Energy Ltd. (USA) (NYSE:EQU) monthly performance is -16.45%.

Many investors appear to be quite bearish on Mitek Systems, Inc. (NASDAQ:MITK), especially if you look at the percentage of the float that is sold short for this stock. Currently, 23.8% of the float is sold short, suggesting an extreme level of bearishness for MITK. Mitek Systems, Inc. (NASDAQ:MITK) in last trading activity ended up at $3.69 with day range of $3.66 – $3.85. Company weekly performance is -12.77% while its quarterly performance stands at -35.15%.Mitek Systems, Inc. (NASDAQ:MITK) is -52.14% away from its 52 week high.

Credit Suisse lowered Leido Holdings, Inc. (NYSE:LDOS) estimates and reiterates its Underperform rating citing declines in Health & Engineering business. Leidos Holdings, Inc. (NYSE:LDOS) belongs to Technology sector with market capitalization of 2.74 billion and has 0.90% insider ownership. In last trading activity company’s stock closed at $34.64 while opening price was $34.77.

Exelixis Inc. (NASDAQ:EXEL) on 28 march announced this week that after a prespecified interim analysis for Cometriq’s Phase III COMET-1 trial in prostate cancer patients, the independent data monitoring committee concluded the trial should continue to its final analysis. On Sunday shares of Exelixis, Inc. (NASDAQ:EXEL) opened at $3.90 and closed at $3.38. This year Company’s Earnings per Share (EPS) growth is -1.33 and next year’s estimated EPS growth is 16.60%. Analysts mean target price for Exelixis, Inc. (NASDAQ:EXEL) is $7.38.

Get Free Updates and Stock Alerts!



*We only send one email per week
Share.

Related Posts

Get Winning Stock Alerts!

Our track record speaks for itself! Our last 7 alerts have delivered combined gains in excess of 300% and there are no signs of slowing down. Join UltimateStockAlerts.com now before you miss out on our next big runner!

We will never sell or share your information.
Close